NO955056L - Enantiomers of 4- (5-fluoro-2,3-dihydro-1H-inden-2-yl) -1H-imidazole - Google Patents

Enantiomers of 4- (5-fluoro-2,3-dihydro-1H-inden-2-yl) -1H-imidazole

Info

Publication number
NO955056L
NO955056L NO955056A NO955056A NO955056L NO 955056 L NO955056 L NO 955056L NO 955056 A NO955056 A NO 955056A NO 955056 A NO955056 A NO 955056A NO 955056 L NO955056 L NO 955056L
Authority
NO
Norway
Prior art keywords
inden
dihydro
imidazole
fluoro
enantiomers
Prior art date
Application number
NO955056A
Other languages
Norwegian (no)
Other versions
NO955056D0 (en
Inventor
Arto Johannes Karjalainen
Raimo Einari Virtanen
Arja Leena Karjalainen
Seppo Sulevi Lennart Parhi
Maire Marjatta Eloranta
Antti Sakari Haapalinna
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of NO955056L publication Critical patent/NO955056L/en
Publication of NO955056D0 publication Critical patent/NO955056D0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Abstract

Optiske isomerer av 4-(5-fluor-2,3-dihydro-lH- inden-2-yl)-lH-imidazol og farmasøytisk akseptable salter derav, deres anvendelse og fremstilling er beskrevet. Begge isomerer er virksomme i behand- ling av kognitive sykdommer.Optical isomers of 4- (5-fluoro-2,3-dihydro-1H-inden-2-yl) -1H-imidazole and pharmaceutically acceptable salts thereof, their use and preparation are described. Both isomers are effective in the treatment of cognitive diseases.

NO955056A 1993-06-18 1995-12-13 Enantiomers of 4- (5-fluoro-2,3-dihydro-1H-inden-2-yl) -1H-imidazole NO955056D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939312669A GB9312669D0 (en) 1993-06-18 1993-06-18 New opticla isomers
PCT/FI1994/000263 WO1995000492A1 (en) 1993-06-18 1994-06-16 Enantiomers of 4-(5-fluoro-2,3-dihydro-1h-inden-2-yl)-1h-imidazole

Publications (2)

Publication Number Publication Date
NO955056L true NO955056L (en) 1995-12-13
NO955056D0 NO955056D0 (en) 1995-12-13

Family

ID=10737432

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955056A NO955056D0 (en) 1993-06-18 1995-12-13 Enantiomers of 4- (5-fluoro-2,3-dihydro-1H-inden-2-yl) -1H-imidazole

Country Status (19)

Country Link
EP (1) EP0703903A1 (en)
JP (1) JPH08511554A (en)
CN (1) CN1125439A (en)
AU (1) AU6972594A (en)
BG (1) BG100218A (en)
CA (1) CA2165459A1 (en)
CZ (1) CZ332195A3 (en)
EE (1) EE9400010A (en)
GB (1) GB9312669D0 (en)
HU (1) HU211271A9 (en)
IL (1) IL109984A0 (en)
LT (1) LT3468B (en)
LV (1) LV11462B (en)
NO (1) NO955056D0 (en)
NZ (1) NZ267427A (en)
PL (1) PL312194A1 (en)
SK (1) SK157095A3 (en)
WO (1) WO1995000492A1 (en)
ZA (1) ZA944346B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6613907B2 (en) 2000-11-08 2003-09-02 Amr Technology, Inc. Process for the production of piperidine derivatives with microorganisms
US8188126B2 (en) 2002-05-16 2012-05-29 Pierre Fabre Medicament Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
FR2839719B1 (en) * 2002-05-16 2004-08-06 Pf Medicament NOVEL IMIDAZOLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
GB0226076D0 (en) 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
FI81092C (en) 1986-05-15 1990-09-10 Farmos Oy Process for the preparation of therapeutically active 4 (5) - (2,3-dihydro-1H-inden-2-yl) imidazole derivatives
GB2225782A (en) 1988-12-09 1990-06-13 Farmos Group Limited Imidazole derivatives useful for treatment of diabetes
GB2244431A (en) 1990-05-31 1991-12-04 Farmos Oy Treatment of age related memory impairment and other cognitive disorders
GB9127050D0 (en) * 1991-12-20 1992-02-19 Orion Yhtymae Oy Substituted imidazole derivatives and their preparation and use

Also Published As

Publication number Publication date
LT3468B (en) 1995-10-25
CA2165459A1 (en) 1995-01-05
LV11462B (en) 1996-12-20
LTIP1959A (en) 1995-01-31
ZA944346B (en) 1995-02-15
HU211271A9 (en) 1995-11-28
WO1995000492A1 (en) 1995-01-05
NZ267427A (en) 1996-10-28
CZ332195A3 (en) 1996-05-15
NO955056D0 (en) 1995-12-13
CN1125439A (en) 1996-06-26
SK157095A3 (en) 1996-06-05
LV11462A (en) 1996-08-20
PL312194A1 (en) 1996-04-01
EP0703903A1 (en) 1996-04-03
BG100218A (en) 1996-06-28
GB9312669D0 (en) 1993-08-04
AU6972594A (en) 1995-01-17
EE9400010A (en) 1995-12-15
IL109984A0 (en) 1994-12-29
JPH08511554A (en) 1996-12-03

Similar Documents

Publication Publication Date Title
CY1115759T1 (en) ANTIBIOTIC COMPOSITIONS FOR EYE TREATMENT
TR200002773T2 (en) Smilagen and anzurogenin-D and their use for the treatment of Alzheimer's.
BR9714363A (en) Substituted pyrazole derivatives for the treatment of cardiac circulatory diseases
DE69108048D1 (en) DERIVATIVES OF HYDROXAMIC ACID AND N-HYDROXY URINE, AND THEIR USE.
TR199802296T2 (en) New 2,3 disubstituted-4 (3H)-quinazolinones
SE9504661D0 (en) New compounds
DE69523155T2 (en) BENZIMIDAZOLONE DERIVATIVES WITH CENTRAL DOPAMINERIC ACTIVITY
BR0017157A (en) 6-hydroxy-indazole derivatives for the treatment of glaucoma
SE9802208D0 (en) Novel compounds
NO971341D0 (en) Promoter for receptor tyrosine kinase TIE
ES2162110T3 (en) DERIVATIVES OF ANTIMALARY QUINOLINE.
MX9709910A (en) Inhibitors of factor xa.
DE69530988T2 (en) BENZIMIDAZOLE DERIVATIVES WITH DOPAMINERIC EFFECT
NO955056L (en) Enantiomers of 4- (5-fluoro-2,3-dihydro-1H-inden-2-yl) -1H-imidazole
NZ513851A (en) Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders
RS50129B (en) Optical active derivative pyridyl-4h-1,2,4-oxadiazine and its application in production of medicaments for treating vascular diseases
FR2733995B1 (en) INHIBITORS OF INACTIVATION OF ENDOGENOUS NEUROPEPTIDES IN PARTICULAR CHOLECYSTOKININ, METHODS OF PREPARING THEIR USE AS MEDICAMENTS AND METHOD OF SCREENING MEDICINAL PRODUCTS
SE9802209D0 (en) Novel compounds
NO991734L (en) Pyrazolinones for the treatment of potency disorders
SE9802538D0 (en) New pharmaceutically active compounds
PT1232173E (en) FUSIDIC ACID DERIVATIVES
DE3865675D1 (en) 1 - ((2-FLUOROPHENYL) (4-FLUOROPHENYL) PHENYLMETHYL) -1H-IMIDAZOLE.
NO982349L (en) New kinoxalindione derivatives, their preparation and use in pharmaceuticals
AU5870298A (en) 1,4-dihydropyridin derivatives and their use in therapy
NO963869L (en) Treatment of diabetic nephropathy with valsartan